{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:30:08Z","timestamp":1792099808524,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1124\/mol.112.083428","type":"journal-article","created":{"date-parts":[[2013,1,5]],"date-time":"2013-01-05T05:16:49Z","timestamp":1357363009000},"page":"681-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["High-Throughput Screening of Small Molecules Identifies Hepcidin Antagonists"],"prefix":"10.1016","volume":"83","author":[{"given":"Eileen","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Sugianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.083428_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-02-411470","article-title":"Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1\/5\/8 signaling","volume":"120","author":"Besson-Fournier","year":"2012","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib2","first-page":"351","article-title":"The anemia of chronic disorders","volume":"3","author":"Cartwright","year":"1966","journal-title":"Semin Hematol"},{"key":"10.1124\/mol.112.083428_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metab"},{"key":"10.1124\/mol.112.083428_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/HPC.0b013e318221e7dd","article-title":"Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine","volume":"10","author":"Ehle","year":"2011","journal-title":"Crit Pathw Cardiol"},{"key":"10.1124\/mol.112.083428_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2008-03-146134","article-title":"The molecular basis of hepcidin-resistant hereditary hemochromatosis","volume":"114","author":"Fernandes","year":"2009","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.130","article-title":"Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)","volume":"40","author":"Finberg","year":"2008","journal-title":"Nat Genet"},{"key":"10.1124\/mol.112.083428_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1124\/mol.112.083428_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.6004\/jnccn.2012.0065","article-title":"Update on safety of ESAs in cancer-induced anemia","volume":"10","author":"Glaspy","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1124\/mol.112.083428_bib9","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1182\/blood-2010-05-286260","article-title":"Detection, evaluation, and management of iron-restricted erythropoiesis","volume":"116","author":"Goodnough","year":"2010","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.soncn.2007.05.006","article-title":"Cytoprotective agents used in the treatment of patients with cancer","volume":"23","author":"Hogle","year":"2007","journal-title":"Semin Oncol Nurs"},{"key":"10.1124\/mol.112.083428_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3177\/jnsv.39.465","article-title":"Pharmacokinetics of thiamin after oral administration of thiamin tetrahydrofurfuryl disulfide to humans","volume":"39","author":"Kitamori","year":"1993","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1124\/mol.112.083428_bib12","first-page":"RA199","article-title":"Thiamine tetrahydrofurfuryl disulfide: a little known therapeutic agent","volume":"10","author":"Lonsdale","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1124\/mol.112.083428_bib13","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2010-03-274571","article-title":"In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2","volume":"116","author":"Maes","year":"2010","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib14","first-page":"265","article-title":"N-acetylcysteine: multiple clinical applications","volume":"80","author":"Millea","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1124\/mol.112.083428_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2005-05-2049","article-title":"The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study","volume":"107","author":"Nemeth","year":"2006","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.112.083428_bib17","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1124\/mol.112.083428_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(70)90328-6","article-title":"The metabolic fate of methyl tetrahydrofurfuryl sulfide and its related compounds in rats","volume":"9","author":"Nishikawa","year":"1970","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.112.083428_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/brain\/awq069","article-title":"Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein\/presenilin-1 transgenic mice","volume":"133","author":"Pan","year":"2010","journal-title":"Brain"},{"key":"10.1124\/mol.112.083428_bib20","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1172\/JCI57693","article-title":"Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload","volume":"121","author":"Preza","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.112.083428_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cmet.2012.03.018","article-title":"Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination","volume":"15","author":"Qiao","year":"2012","journal-title":"Cell Metab"},{"key":"10.1124\/mol.112.083428_bib22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2174\/092986711794927685","article-title":"Pleiotropic effects of cardioactive glycosides","volume":"18","author":"Riganti","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1124\/mol.112.083428_bib23","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib24","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1182\/blood-2006-10-051755","article-title":"Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation","volume":"109","author":"Roy","year":"2007","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib25","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bcmd.2004.12.002","article-title":"Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features","volume":"34","author":"Sham","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"10.1124\/mol.112.083428_bib27","first-page":"242","volume":"30","year":"1971","journal-title":"Journal of the Takeda Research Laboratories"},{"key":"10.1124\/mol.112.083428_bib28","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","article-title":"Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats","volume":"118","author":"Theurl","year":"2011","journal-title":"Blood"},{"key":"10.1124\/mol.112.083428_bib29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.112.083428_bib30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin\u2014a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/mol.112.083428_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science"},{"key":"10.1124\/mol.112.083428_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1124\/mol.112.083428_bib33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.25746","article-title":"Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24036678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24036678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.083428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:03:52Z","timestamp":1739963032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24036678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0026895X24036678"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.083428","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Throughput Screening of Small Molecules Identifies Hepcidin Antagonists","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.083428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}